RELACORILANT
US Stocks: Corcept Therapeutics shares surge 32% as lead drug gets FDA nod for ovarian cancerCorcept Therapeutics shares surged after the FDA approved its drug, Lifyorli, for a tough ovarian cancer. This new therapy, combined with c...
- Load More